Department of Preventive Medicine, USC Keck School of Medicine, 2001 N. Soto Street, Los Angeles, CA 90089, United States.
Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States.
Atherosclerosis. 2014 Jan;232(1):165-70. doi: 10.1016/j.atherosclerosis.2013.10.034. Epub 2013 Nov 15.
The primary objective was to evaluate predictors of HDL anti-oxidant function in young adults.
High-density lipoprotein (HDL) cholesterol is considered a protective factor for cardiovascular disease (CVD). However, increased levels are not always associated with decreased cardiovascular risk. A better understanding of the importance of HDL functionality and how it affects CVD risk is needed.
Fifty non-Hispanic white subjects from the Testing Responses on Youth (TROY) study were randomly selected to investigate whether differences in HDL anti-oxidant function are associated with traditional cardiovascular risk factors, including carotid intima media thickness (CIMT), arterial stiffness and other inflammatory/metabolic parameters. HDL anti-oxidant capacity was evaluated by assessing its ability to inhibit low-density lipoprotein (LDL) cholesterol oxidation by air using a DCF-based fluorescent assay and expressed as a HDL oxidant index (HOI). The associations between HOI and other variables were assessed using both linear and logistic regression.
Eleven subjects (25%) had an HOI ≥ 1, indicating a pro-oxidant HDL. Age, LDL, high sensitivity C-reactive protein (hsCRP), and paraoxonase activity (PON1), but not HDL, were all associated with HOI level in univariate linear regression models. In multivariate models that mutually adjusted for these variables, LDL remained the strongest predictor of HOI (0.13 increase in HOI per 1 SD increase in LDL, 95% CI 0.04, 0.22). Atherogenic index of plasma, pulse pressure, homocysteine, glucose, insulin, CIMT and measurements of arterial stiffness were not associated with HOI in this population.
These results suggest LDL, hsCRP and DBP might predict HDL anti-oxidant function at an early age.
主要目的是评估年轻人高密度脂蛋白(HDL)抗氧化功能的预测因子。
高密度脂蛋白(HDL)胆固醇被认为是心血管疾病(CVD)的保护因素。然而,水平升高并不总是与心血管风险降低相关。需要更好地了解 HDL 功能的重要性及其如何影响 CVD 风险。
从 Testing Responses on Youth(TROY)研究中随机选择了 50 名非西班牙裔白人受试者,以调查 HDL 抗氧化功能的差异是否与传统心血管危险因素相关,包括颈动脉内膜中层厚度(CIMT)、动脉僵硬度和其他炎症/代谢参数。通过使用基于 DCF 的荧光测定法评估其抑制低密度脂蛋白(LDL)胆固醇氧化的能力来评估 HDL 抗氧化能力,并表示为 HDL 氧化剂指数(HOI)。使用线性和逻辑回归评估 HOI 与其他变量之间的关联。
11 名受试者(25%)的 HOI≥1,表明 HDL 具有促氧化剂作用。年龄、LDL、高敏 C 反应蛋白(hsCRP)和对氧磷酶活性(PON1),但不是 HDL,在单变量线性回归模型中均与 HOI 水平相关。在相互调整这些变量的多变量模型中,LDL 仍然是 HOI 的最强预测因子(LDL 每增加 1 SD,HOI 增加 0.13,95%CI 0.04,0.22)。在该人群中,血浆致动脉粥样硬化指数、脉压、同型半胱氨酸、葡萄糖、胰岛素、CIMT 和动脉僵硬度测量均与 HOI 无关。
这些结果表明 LDL、hsCRP 和 DBP 可能在早期预测 HDL 抗氧化功能。